Research Topics
| Robert G HartSummaryAffiliation: University of Texas Health Science Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trialsRobert G Hart
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio 78229 3900, USA
Stroke 33:2722-7. 2002..Until recently, the value of antithrombotic therapies for acute stroke management has been based on empiric evidence...
What's new in stroke? The top 10 studies of 2006-2008. Part IRobert G Hart
Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
Pol Arch Med Wewn 118:650-7. 2008..These trials, together involving 39,742 participants, have influenced 2008 European and North American guidelines for secondary prevention of noncardioembolic stroke, and these guideline recommendations are reviewed...
Neuroprotection trials in Parkinson's disease: systematic reviewRobert G Hart
Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
Mov Disord 24:647-54. 2009..Future trials should include participants with wider ranges of disease stages and assess broader neurological outcomes...
Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trialRobert G Hart
Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Cerebrovasc Dis 25:344-7. 2008..Aspirin offers modest reduction in stroke in patients with atrial fibrillation. Whether combination of aspirin with clopidogrel offers additional protection is unclear...
An assessment of guidelines for prevention of ischemic strokeRobert G Hart
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, 78229 3900, USA
Neurology 59:977-82. 2002..To compare methods and key management recommendations from recent stroke prevention guidelines...
Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhageRobert G Hart
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
J Thromb Thrombolysis 25:26-32. 2008..A wide range of acute treatments to urgently reverse anticoagulation have been recommended by experts, but prevention is a far better option than treatment of this devastating problem...
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationRobert G Hart
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
Ann Intern Med 146:857-67. 2007..Atrial fibrillation is a strong independent risk factor for stroke...
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideasRobert G Hart
Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Stroke 36:1588-93. 2005..We review the incidence, risk factors, and predictors of ICH in patients receiving long-term anticoagulation or antiplatelet therapy...
Lessons from the Stroke Prevention in Atrial Fibrillation trialsRobert G Hart
Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, Texas 78229 3900, USA
Ann Intern Med 138:831-8. 2003..For patients at moderate risk for stroke, patient preferences and access to reliable anticoagulation monitoring are particularly relevant...
What's new in stroke? The top 10 studies of 2006-2008. Part IIRobert G Hart
Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
Pol Arch Med Wewn 118:747-55. 2008..These recent studies add important pieces to the complex puzzle of optimal stroke prevention and treatment...
What's new in stroke? The top 10 studies of 2009-2011: part IIRobert G Hart
Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, United States
Pol Arch Med Wewn 121:200-7. 2011..For younger patients, periprocedural risks were comparable with stenting or endarterectomy, but long-term outcomes are required to assess the relative merits of the two procedures...
Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) InvestigatorsR G Hart
University of Texas Health Science Center, San Antonio, TX, USA
Stroke 30:1223-9. 1999..We explore factors associated with ischemic stroke in AF patients taking aspirin...
Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trialRobert G Hart
Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr, MSC 7883, San Antonio, TX 78229 3900, USA
Stroke 35:948-51. 2004..Transient ischemic attacks (TIAs) are infrequent in patients with atrial fibrillation, and little is known about the long-term prognosis and response to antithrombotic therapy...
Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesisR G Hart
Department of Medicine Division of Neurology, University of Texas Health Science Center in San Antonio, TX 78284 7883, USA
Cerebrovasc Dis 9:215-7. 1999..Oral anticoagulation with vitamin K antagonists increases the risk of intracranial hemorrhage; whether addition of aspirin to oral anticoagulation augments this risk is unclear...
Atrial fibrillation and thromboembolism: a decade of progress in stroke preventionR G Hart
Department of Medicine Neurology, University of Texas Health Sciences Center, San Antonio 78284, USA
Ann Intern Med 131:688-95. 1999..Making the most of this promise calls for appreciation of the epidemiology of atrial fibrillation and the concept of risk specificity in the face of diverse therapeutic options...
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation InvestigatorsR G Hart
Department of Medicine, University of Texas Health Science Center, San Antonio 78284, USA
J Am Coll Cardiol 35:183-7. 2000..This study was performed to characterize the risk of stroke in elderly patients with recurrent intermittent atrial fibrillation (AF)...
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypothesesR G Hart
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio 78284, USA
Arch Neurol 57:326-32. 2000..Aspirin therapy reduces stroke by about 25% for persons with atherosclerotic vascular disease, but the effect in those without clinically apparent vascular disease is distinctly different...
Stroke prevention in atrial fibrillationR G Hart
Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284 7883, USA
Curr Cardiol Rep 2:51-5. 2000..For those with moderate stroke risk, individual bleeding risks during anticoagulation and patient preferences should guide antithrombotic therapy...
Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseRobert G Hart
Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Clin J Am Soc Nephrol 6:2599-604. 2011..The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown...
What's new in stroke? The top 10 for 2004/05Silvina B Tonarelli
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
J Am Geriatr Soc 54:674-9. 2006..The practical management implications of these studies refine and improve care of geriatric patients with cerebrovascular disease...
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsSantiago Palacio
Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
Stroke 43:2157-62. 2012..We assessed the effect of the addition of clopidogrel to aspirin on mortality in a meta-analysis of published randomized trials...
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinionMaria I Aguilar
Department of Neurology, Mayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
Mayo Clin Proc 82:82-92. 2007..Reasonable management based on expert opinion includes a wide range of additional measures to reverse anticoagulation in the absence of solid evidence...
Atrial fibrillation and stroke preventionRobert G Hart
Department of Medicine, Division of Neurology, University of Texas Health Science Center, San Antonio, USA
N Engl J Med 349:1015-6. 2003
Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) studyDavid G Sherman
University of Texas Health Science Center, San Antonio, USA
Arch Intern Med 165:1185-91. 2005..The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study was a multicenter comparison of high-risk patients with AF who were randomized to either a sinus rhythm control or a rate control strategy...
Antithrombotic therapies for stroke prevention in atrial fibrillationRobert G Hart
Department of Medicine/Neurology, University of Texas Health Science Center, San Antonio, Texas, USA
Adv Neurol 92:249-56. 2003
Aspirin dosage and thromboxane synthesis in patients with vascular diseaseRobert G Hart
University of Texas Health Science Center, San Antonio 78229-3900, USA
Pharmacotherapy 23:579-84. 2003..4 ng/mmol creatinine. CONCLUSION: Different aspirin dosages significantly affect serum and urinary markers of thromboxane synthesis...
Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes studyPablo E Pergola
Department of Medicine, Division of Nephrology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Blood Press Monit 12:1-8. 2007..Reliable and unbiased blood pressure measurement is critical to successful completion of the trial...
Headache improvement through TMD stabilization appliance and self-management therapiesEdward F Wright
University of Texas Health Science Center, San Antonio, USA
Cranio 24:104-11. 2006..722). These results suggest appliance and self-management therapies can be beneficial for many severe headache patients, irrespective of the headache type (tension-type, migraine without aura, and migraine with aura)...
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhageR D Bailey
Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Neurology 56:773-7. 2001..To characterize the rates of recurrent intracranial hemorrhage (ICH), ischemic stroke, and death in survivors of primary ICH...
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trialC S Kase
Department of Neurology, Boston University School of Medicine, MA 02118, USA
Neurology 57:1603-10. 2001..To analyze the frequency, clinical characteristics, and predictors of symptomatic intracerebral hemorrhage (ICH) after intraarterial (IA) thrombolysis with recombinant pro-urokinase (r-proUK) in acute ischemic stroke...
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III InvestigatorsM Zabalgoitia
University of Texas Health Science Center at San Antonio, 78284 7872, USA
J Am Coll Cardiol 31:1622-6. 1998..This study explored the mechanisms linking clinical and precordial echocardiographic predictors to thromboembolism in atrial fibrillation (AF) by assessing transesophageal echocardiographic (TEE) correlations...
What's new in stroke? The top 10 studies of 2009-2011: part IWiesław J Oczkowski
Vascular Neurology, Division of Neurology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Pol Arch Med Wewn 121:193-9. 2011....
Thrombolysis for acute stroke in hemodialysis: international survey of expert opinionSantiago Palacio
Department of Neurology, University of Texas Health Science Center, 8300 Floyd Curl Drive MC 7883, San Antonio, TX 78229 3900, USA
Clin J Am Soc Nephrol 6:1089-93. 2011..The objective of this study was for stroke experts to define the range of management concerning thrombolytic treatment of acute stroke in hemodialysis...
National Stroke Association guidelines for the management of transient ischemic attacksS Claiborne Johnston
Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
Ann Neurol 60:301-13. 2006..Management varies widely, and most published guidelines have not been updated in several years. We sought to create comprehensive, unbiased, evidence-based guidelines for the management of patients with transient ischemic attacks...
Stroke risk in an elderly population with atrial fibrillationW M Feinberg
Department of Neurology, University of Arizona Health Sciences Center, Tucson, USA
J Gen Intern Med 14:56-9. 1999..7% per year (95% CI 0.6, 3.8). Many people with AF in this population-derived cohort had relatively low rates of stroke. Further studies to reliably stratify stroke risk in patients with AF are needed...
Neurologic manifestations of cardiogenic embolism: an updateSantiago Palacio
Department of Medicine, Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
Neurol Clin 20:179-93, vii. 2002..Their role as independent risk factors for stroke and management implications based on recent evidence, along with characterization of schemes for antithrombotic management of patients with atrial fibrillation are reviewed...
Late-developing cerebral arteropathy after pyogenic meningitisSantiago Palacio
Department of Medicine (Neurology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, Texas 78229-3900, USA
Arch Neurol 60:431-3. 2003..The arterial lesions stabilized, and the patient remained asymptomatic. CONCLUSION: Progressive intracranial arterial stenosis can evolve months after meningitis and should be added to the list of recognized vascular complications...
Antithrombotic therapy for atrial fibrillationGregory Y H Lip
University Department of Medicine, City Hospital, Birmingham
BMJ 325:1022-5. 2002
Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is inCarl van Walraven
Clinical Epidemiology Unit Ottawa Health Research Institute, Ottawa, Ontario, Canada
Card Electrophysiol Rev 7:374-8. 2003..Since high-risk AF patients appear to benefit most from OAC, determining stroke risk in AF patients is very important...
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillationRobert G Hart
Ann Intern Med 147:590-2. 2007
Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factorsDwayne S G Conway
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
Circulation 106:1962-7. 2002..Further longitudinal studies are now needed to confirm relationships between endothelial damage/dysfunction, platelet activation, and stroke in AF...
Did we really need another comparison of warfarin with aspirin? An assessment of the BAFTA trialRobert G Hart
Pol Arch Med Wewn 117:443-5. 2007
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)Jeff S Healey
Population Health Research Institute, McMaster University, 237 Barton St E, Hamilton, Ontario, Canada
Stroke 39:1482-6. 2008..However, because OAC carries important bleeding complications, risk stratification schemes have been devised to identify patients for whom the absolute benefits of OAC exceed its risks...
Carotid-artery stenting versus endarterectomySilvina B Tonarelli
N Engl J Med 352:624-7; author reply 624-7. 2005
Making anticoagulation saferRobert G Hart
Neurology 59:153. 2002
Do we really need a better way to give heparin in acute cerebral ischemia?Robert G Hart
Stroke 33:659-60. 2002
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosisGregory Y H Lip
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK
Stroke 38:1229-37. 2007....
ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disordersGregory Y H Lip
BMJ 325:1161-3. 2002
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysisCarl van Walraven
Clinical Epidemiology Unit, Ottawa Health Research Institute, F 6, Ottawa Hospital, Civic Campus, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9
JAMA 288:2441-8. 2002..Patients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke and other vascular events...
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillationDwayne S G Conway
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
Circulation 107:3141-5. 2003....
A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirinCarl van Walraven
Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa Hospital, Ontario, Canada
Arch Intern Med 163:936-43. 2003....
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attackHisatomi Arima
George Institute for International Health, University of Sydney, Australia
Stroke 36:2164-9. 2005..4). CONCLUSIONS: For most patients with atrial fibrillation, routine blood pressure-lowering is likely to provide protection against major vascular events additional to that conferred by anticoagulation...
Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patientsRobert G Hart
Stroke 37:334; author reply 334-5. 2006
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisalAnders Oden
Statistical consultant, Romelanda, Sweden
Thromb Res 117:493-9. 2006..To study how stroke and mortality rates vary with different degrees of anticoagulation reflected by the international normalised ratio (INR) we critically assess information from different sources...
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirinBrian F Gage
Division of General Medical Sciences, Washington University School of Medicine Campus Box 8005, 660 S Euclid Ave, St Louis, MO 63110, USA
Circulation 110:2287-92. 2004..This prospective cohort study tested the predictive accuracy of 5 stroke risk stratification schemes...
Why is WASID an important clinical trial?Robert G Hart
Neuroepidemiology 22:101-2. 2003
Predictors of stroke in patients paced for sick sinus syndromeArnold J Greenspon
Division of Cardiology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
J Am Coll Cardiol 43:1617-22. 2004..This study was an analysis of factors associated with stroke in a population of patients paced for sinus node dysfunction in a large prospective clinical trial (Mode Selection Trial [MOST])...
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillationGregory Y H Lip
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
Stroke 37:2294-300. 2006..This study determined the additive role of plasma vWf levels to clinical factors for risk stratification in patients with AF...
Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspectiveRobin A Conwit
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Neuroscience Center, Bethesda, MD 20850, USA
Ann Emerg Med 45:388-92. 2005..We review National Institute of Neurologic Disorders and Stroke principles of data and safety monitoring and provide examples to illustrate key concepts...
Serum potassium level and dietary potassium intake as risk factors for strokeRobert G Hart
Neurology 60:1869-70; author reply 1870. 2003
Clinical research in primary stroke prevention: needs, opportunities, and challengesBarbara Radziszewska
National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA
Neuroepidemiology 25:91-104. 2005..The scientific or logistic barriers to stroke primary prevention trials are challenging, but are not insurmountable...
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing CouncLarry B Goldstein
Stroke 37:1583-633. 2006..CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk...
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing CouncLarry B Goldstein
Circulation 113:e873-923. 2006..CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk...
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillationRobert G Hart
Stroke 39:1901-10. 2008..Additional research to identify an optimum scheme for primary prevention and subsequent standardization of recommendations may lead to more uniform selection of patients for anticoagulant prophylaxsis...
